Quan Gao

Hangzhou, 311121, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics.

Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics.

Journal: Chinese journal of integrative medicine

Published: October 31, 2025

NPCDR 2.0: the activity and structure landscape of natural product-based drug combination.

NPCDR 2.0: the activity and structure landscape of natural product-based drug combination.

Journal: Nucleic acids research

Published: September 14, 2025

The antitumor mechanisms of Huangqin Houpo decoction and its effect on chemotherapy-induced toxicity in colorectal cancer.

The antitumor mechanisms of Huangqin Houpo decoction and its effect on chemotherapy-induced toxicity in colorectal cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 14, 2025

Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy.

Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy.

Journal: Experimental hematology & oncology

Published: July 03, 2025

Artemisiae Annuae Herba: from anti-malarial legacy to emerging anti-cancer potential.

Artemisiae Annuae Herba: from anti-malarial legacy to emerging anti-cancer potential.

Journal: Theranostics

Published: April 09, 2025

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs.

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs.

Journal: Scientific reports

Published: March 20, 2025

Honokiol-Magnolol-Baicalin Possesses Synergistic Anticancer Potential and Enhances the Efficacy of Anti-PD-1 Immunotherapy in Colorectal Cancer by Triggering GSDME-Dependent Pyroptosis.

Honokiol-Magnolol-Baicalin Possesses Synergistic Anticancer Potential and Enhances the Efficacy of Anti-PD-1 Immunotherapy in Colorectal Cancer by Triggering GSDME-Dependent Pyroptosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 17, 2024

Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune-Checkpoint Inhibitors.

Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune-Checkpoint Inhibitors.

Journal: Phytotherapy research : PTR

Published: May 21, 2024

Honokiol enhances the sensitivity of cetuximab in KRASG13D mutant colorectal cancer through destroying SNX3-retromer complex.

Honokiol enhances the sensitivity of cetuximab in KRASG13D mutant colorectal cancer through destroying SNX3-retromer complex.

Journal: Theranostics

Published: April 10, 2024

Active metabolites combination therapies: towards the next paradigm for more efficient and more scientific Chinese medicine.

Active metabolites combination therapies: towards the next paradigm for more efficient and more scientific Chinese medicine.

Journal: Frontiers in pharmacology

Published: February 28, 2024

Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells.

Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells.

Journal: Chinese journal of integrative medicine

Published: July 24, 2023

Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.

Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.

Journal: Advanced drug delivery reviews

Published: December 14, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026